Welcome to LookChem.com Sign In|Join Free

CAS

  • or

111507-07-4

Post Buying Request

111507-07-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111507-07-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 111507-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,5,0 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 111507-07:
(8*1)+(7*1)+(6*1)+(5*5)+(4*0)+(3*7)+(2*0)+(1*7)=74
74 % 10 = 4
So 111507-07-4 is a valid CAS Registry Number.

111507-07-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name D-leucine isopentylamide

1.2 Other means of identification

Product number -
Other names Pentanamide, 2-?amino-?4-?methyl-?N-?(3-?methylbutyl)?-?, (2R)?-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111507-07-4 SDS

111507-07-4Downstream Products

111507-07-4Relevant articles and documents

NOVEL DRUGS FOR DEMENTIA

-

Example 2, (2008/06/13)

The invention is directed to compounds that are prodrugs containing a chemical delivery system (CDS) moiety and a cysteine protease inhibitor moiety. The CDS moiety targets the prodrug to the brain or central nervous system. The cysteine protease inhibitor inhibits cysteine proteases upon release from the prodrug. Cysteine protease inhibitors are effective for treating dementia, Alzheimer's disease and vascular dementia. Targeting the brain or central nervous system offers significant advantages in treating these conditions and diseases. A preferred CDS prodrug is a dihydrotrigoneline CDS moiety coupled to an epoxysuccinyl peptide cysteine protease inhibitor moiety.

Efficient synthetic method for ethyl (+)-(2S,3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbam oyl]-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases

Tamai,Yokoo,Murata,Oguma,Sota,Sato,Kanaoka

, p. 1098 - 1104 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 111507-07-4